Bibliographie : Cannabinoïdes et Douleurs Neuropathiques

Bibliographie CANNABINOÏDES et Douleurs Neuropathiques

Dr Christian SUEUR, GRECC, octobre 2018.

 

  1. ABRAMS D.I. et al. : Short-term effects of cannabinoids in patients with HIV-1 infection : a randomized, placebo-controlled clinical trial, Annals of Internal Medicine, 2003, 139, 4, 258-266.
  2. ABRAMS D.I., JAY C.A., SHADE S.B. et al. : Cannabis in painful HIV-associated sensory neuropathy : a randomized placebo-controlled trial, Neurology, 2007, 68, 515-521. DOI : 10.1212/01.wnl.0000253187.66183.9c
  3. ABRAMS D.I., COUEY P., SHADE S.B., KELLY M.E., BENOWITZ N.L. : Cannabinoid-Opioid Interaction in chronic Pain, Clinical Pharmacology & Therapeutics, 2011, 90, 6, 844-51. DOI : 10.1038/CLPT.2011.188
  4. AGGARWAL S.K., CARTER G.T., SULLIVAN M.D. et al. : Medicinal use of cannabis in the United States : historical perspectives, current trends and future directions, Journal of Opioid Management, 2008, 5, 153-168.
  5. ALLAN G.M., FINLEY C.R., TON J., PERRY D. et al : Systematic review of systematic reviews for medical cannabinoids. Pain, nausea and vomiting, spasticity and harms, Canadian Family Physician, 2018, 64, e78-94.
  6. ANDREAE M.H., CARTER G.M., SHAPARIN N. et al. : Inhaled cannabis for chronic neuropathic pain : a meta-analysis of individual patient data, Journal of Pain, 2015, 6, 12, 1221-1232.
  7. BACHHUBER M.A., SALONER B., CUNNINGHAM C.O. : Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010, JAMA Internal Medicine, 2014, 174, 1668-1673.
  8. BACHHUBER M.A., ARNSTEN J.H., STARRELS J.L., CUNNINGHAM C.O. : Willingness to Participate in Longitudinal Research Among People with Chrnic Pain Who Take Medical Cannabis : A Cross-Sectional Survey, Cannabis and Cannabinoid Research, 2018, 3, 1, 45-53.
  9. BARON E.P., LUCAS P., EADES J., HOGUE O. : Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis and chronic pain in a medicinal cannabis cohort, The Journal of Headache and Pain, 2018, 19, 37.
  10. BEAULIEU P., WARE  : Reassessment of the role of cannabinoids in the management of pain, Current Opinions in Anaesthesiology, 2007, 20, 473-477.
  11. BELTRAMO M. : The cannabinoid system and pain : towards new drugs ?, Soc. Biol, 2009, 203, 1, 99-106.
  12. BERRENDERO F., MALDONADO R. : Involvement of the opioid system in the anxiolytic-like effects induced by delta 9-tetrahydrocannabinol, Psychopharmacology (Berl), 2002, 163, 1, 111-117.
  13. BOEHNKE K.F., LITINAS E., CLAUW D.J. : Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain, Journal of Pain, 2016, 17, 739-744.
  14. BOYCHUK D.G., GODDARD G., MAURO G., ORELLANA M.F. : The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain : a Systematic Review, Journal of Oral and Facial Pain and Headache, 2015, 29, 1, 7-14.
  15. BREITBART W., PASSIK S., McDONALD M.V. et al : Patient-related barriers to pain management in ambulatory AIDS patients, Pain, 1998, 76, (1-2), 9-16.
  16. BRITCH S.C., WILEY J.L., ZHIHAO Y., CLOWERS B.H., CRAFT R.M. : Cannabidiol-Delta9-tetrahydrocannabinol interactions on acute pain and locomotor activity, Drug and Alcohol Dependence, 2017, 175, 187-197.
  17. BURNS T.L., INECK J.R. : Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatmant of Chronic Pain, The Annals of Pharmacotherapy, 2006, 40, 251-260.
  18. BURSTEIN S.H. : In humans, ajulemic acid has more favorable side-effect profile than THC for the treatment of chronic neuropathic pain, Cannabinoids, 2007, 2, 1, 1-2.
  19. CAMPBELL F.A., TRAMER M.R., CARROLL D., REYNOLDS D.J., MOORE R.A., McQUAY H.J. : Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review, British Medical Journal, 2001, 323, 13-16.
  20. CASEY S.L., VAUGHAM C.W. : Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain, Medicines, 2018, 5, 67, 7 p.
  21. CASSARET D., KARLAWISH J., SHANKAR P.et al. : Obtaining informed consent for clinical pain research : patients’ concerns and information needs, Pain, 2001, 92, 71-79.
  22. CASSARET D., KARLAWISH J., SHANKAR P.et al. : Obtaining informed consent for clinical pain research : do patients with advanced cancer and patients with chronic pain have differents concerns, Journal of Pain Symptom Management, 2002, 24, 506-516.
  23. Center for Medicinal Cannabis Research : Efficacy of inhaled cannabis in diabetic painful peripheral neuropathy, gov. http://ClinicalTrials.gov/show/NCT00781001. Accessed April 7, 2014.
  24. CHENG Y., HITCHCOCK S.A. : Targeting cannabinoid agonists for inflammatory and neuropathic pain, Expert Opinion in Investigational Drugs, 2007, 16, 7, 951-965.
  25. COOPER Z.D., HANEY M. : Sex-dependent effects of cannabis –induced analgesia, Drug and Alcohol Dependence, 2016.
  26. Da FONSECA PACHECCO D., KLEIN A., de CASTRO PEREZ A. et al : The μ-opioid receptor agonist morphine, but not agonists at δ- or κ-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors, British Journal of Pharmacology, 2008, 154, 5, 1143-1149.
  27. DESROCHES J., BEAULIEU P. : Système cannabinoïde et douleur : quelle place en thérapeutique ?, Revue Médicale Suisse, 2008, 4, 1505-1513.
  28. DESROCHES J., CHARRONS., BOUCHARD J.F., BEAULIEU P. : Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors, Neuropharmacology, 2014, 77, 441-452.
  29. DONVITO G., NASS S.R., WILKERSON J.L., CURRY Z.A. et al : The endogenous Cannabinoid System : A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain, Neuropsychopharmacology, 2018, 43, 52-79.
  30. ELLIS R.J., TOPEROFF W., VAIDA F. et al. : Smoked Medicinal Cannabis for Neuropathic Pain in HIV : A Randomized, Crossover Clinical Trial, Neuropsychopharmacology, 2009, 34, 3, 672-680.
  31. FANELLI G., DE CAROLIS G., LEONARDI et al : Cannabis and intractable chronic pain : an explorative retrospective analysis of Italian Cohort of 614 patients, Journal of Pain Research, 2017, 10, 1217-1224. (PubMed ID: 28579820).
  32. FARRAR J.T., YOUNG J.R., LAMOREAUX L., WERTH J.L., POOLE R.M. : Clinical Importance of changes in chronic pain intensity measured on an 11-point numerical rating scale, Pain, 2001, 94, 149-158.
  33. GW Pharmaceuticals Ltd. : A study of cannabis based medicine extracts and placebo in patients with pain due to spinal cord injury, gov. http://ClinicalTrials.gov/show/NCT01606202. Accessed April 7, 2014.
  34. HAUSER W., PETZKE F., FITZCHARLES M.-A. : Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management – An overview of systematic reviews, European Journal of Pain, 2017, 16 p.
  35. HILL K.P. : Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems : A Clinical Review, JAMA, 2015, 313, 24, 2474-2483. doi: 10.1001/jama.2015.6199.
  36. HOSKING R.D., ZAJICEK J.P. : Therapeutic potential of cannabis in pain medicine, British Journal of Anaesthesiology, 2008, 101, 1, 59-68.
  37. HOUSER S.J. et al. : Dynorphin B and spinal analgesia : induction of antinociception by the cannabinoids CP55,940, delta 9-THC, and anandamide, Brain Research, 2000, 857, (1-2), 337-342.
  38. HUANG S.M., WALKER J.M. : Cannabinoid targets for pain therapeutics, in « Cannabinoids as Therapeutics », Ed. R. Mechoulam, Birkhäuser Verlag, Switzerland, 2005.
  39. ING LORENZINI K., BROERS B., LALIVE P.H. et al : Cannabinoïdes médicaux dans les douleurs chroniques : aspects pharmacologiques, Revue Médicale Suisse, 2015, 11, 1390-1394.
  40. ISKEDJIAN M., BEREZA B., GORDON A., PIWKO C., EINARSON T.R. : Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis –related pain, Current Medical Research and Opinion, 2007, 23, 1, 17-24. (PubMed : 17257464).
  41. JOCHIMSEN P.R., LAWTON R.L., VERSTEEG K., NOYES J.R. : Effect of benzo-pyranoperidine a Δ9-THC congener, on pain, Clinical Pharmacology and Therapeutics, 1978, 24, 223–227.
  42. KARST M., SALIM K., BURSTEIN S. et al. : Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain : a randomised controlled trial, JAMA, 2003, 290, 13, 1757-1762.
  43. LUCAS P. : Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain, Journal of Psychoactive Drugs, 2012, 44, 125-133.
  44. LUCAS P., WALSH Z. : Medical cannabis access, use, and substitution for prescription opioids and other substances : a survey of authorized medical cannabis patients, International Journal of Drug Policy, 2017, 42, 30-35.
  45. LYNCH M.E., WARE M.A. : Cannabinoids for the treatment of chronic non-cancer pain : an updated systematic review of randomized controlled trials, Journal of Neuroimmune Pharmacology, 2015, 10-293-301.
  46. MARIN S. et al. : Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55, 940 in male rats, Pharmacol Biochem Behav, 2003, 74, 3, 649-656.
  47. MARTIN-SANCHEZ E., FURUKAWA T.A., TAYLOR J., MARTIN J.L.R. : Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain, Pain Medicine, 2009, 10, 1353-1368.
  48. MENG H., JOHNSTON B., ENGLESAKIS M., MOULIN D., BHATIA A. : Selective Cannabinoids for Chronic Neuropathic Pain : A Systematic Review and Meta-analysis, Anesthesia and Analgesia, 2017, 125, 5, 1638-1652.
  49. MERLIN J.S., BULLS H.W., VUKOVICH L.A., EDELMAN E.J., STARRELS J.L. : Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV : a systematic review, AIDS Care, 2016, 28, 12.

DOI : 10.1080/09540121.2016.1191612

  1. MUCKE M., PHILLIPS T., RADBRUCH L., PETZKE F., HAUSER W. : Cannabis-based medicines for chronic neuropathic pain in adults, Cochrane Database of Systematic Reviews, 2018, 2, 90 p.
  2. O’HEARN S., DIAZ P., WAN B.A., DeANGELIS C., LAO N., MALEK L., CHOW E., BLAKE A. : Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain : a selected review of preclinical studies, Annals of Palliative Medicine, 2017, doi : 10.21037.
  3. PERTWEE R.G. : Cannabinoid receptors and pain, Progress in Neurobiology, 2001 63, 5, 569-611.
  4. PETZKE F., ENAX-KRUMOVA E.K., HAUSER W. : Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies, Schmerz, 2016, 30, 1, 62-88.
  5. PIOMELLI D., WEISS S., BOYD G., PACULA R.L., COOPER Z.D. : Cannabis and the Opioid Crisis, Cannabis and Cannabinoid Research, 2018, 3, 1, 108-116.
  6. PIPER B.J., DeKEUSTER R.M., BEALS M.N. et al. : Substitution of medical cannabis for pharmaceutical agents for pain, anxiety and sleep, Journal of Psychopharmacology, 2017, 31, 569-575.
  7. PUGH G. Jr et al. : Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 and the spinal cord, Journal of Pharmacology and Experimental Therapeutics, 1997, 281, 2, 730-737.
  8. RAHN E.J., HOHMAN A.G. : Cannabinoids as Pharmacotherapies for Neuropathic Pain : From the Bench to the Bedside, Neurotherapeutics, 2009, 6, 4, 713-737.
  9. RANI SAGAR R., BURSTON J.J., WOODHAMS S.G., CHAPMAN V. : Dynamic changes to the endocannabinoid system in models of chronic pain, Philosophical Transactions of the Royal Society Bulletin in Biological Sciences, 2012, 367, 1607, 3300-3311.
  10. REIMAN A., WELTY M., SOLOMON P. : Cannabis as a substitute for opioid-based pain medication : patient self report, Cannabis and Cannabinoid Research, 2017, 2, 160-166.
  11. RICE A.S., FARGUHAR-SMITH W.P., NAGY I. : Endocannabinoids and pain : spinal and peripheral analgesia in inflammation and neuropathy, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2002, 66, 2-3, 243-256.
  12. RUSSO E.B. : Cannabinoids in the management of difficult to treat pain, Therapeutics and Clinical Risk Management, 2008, 4, 1, 245-259.
  13. RYZ N.R., REMILLARD D.J., RUSSO E.B. : Cannabis Roots : Av traditionnal Therapy with Future Potential for treating Inflammation and pain, Cannabis and Cannabinoid Research, 2017, 2, 1, 210-216.
  14. SAGAR D.R., JHAVERI M., CHAPMAN V. : Targeting the cannabinoid system to produce analgesia, Current Topics in Behavioral Neurosciences, 2009, 1, 275-287.
  15. SAVAGE S.R., ROMERO-SANDOVAL A., SCHATMAN M., FANCIULLO G., McCARBERG B., WARE M. : Cannabis in Pain Treatment : Clinical and Research Considerations, Journal of Pain, 2016, 17, 6, 654-668.
  16. SHARON H., GOLDWAY N., GOOR-ARYEH I., EISENBEREG E., BRILL S. : Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain, Journal of Pain Research, 2018, 11, 1411-1419.
  17. SILVA N.R., GOMES F.V., FONSECA M.D., MECHOULAM R., BREUER A., CUNHA T.M., GUIMARAES F.S. : Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative, Progress in Neuropsychopharmacology & Biological Psychiatry,
  18. SMITH P.F. : Cannabinoids in the treatment of pain and spasticity in multiple sclerosis, Current Opinion in Investigational Drugs, 2002, 3, 6, 859-864.
  19. SOHLER N.L., STARRELS J.L., KHALID L. et al : Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain, Substance Use & Misuse, 2018, 1-6.
  20. STAROWICZ K., FINN D.P. : Cannabinoids and Pain : Sites and Mechanism of Action, Advances in Pharmacology, 2017, 80, 437-475.
  21. STOCKINGS E., CAMPBELL G., HALL W.D., NIELSEN S., ZAGIC D., RAHMAN R., MURNION B., FARRELL M., WEIR M., DEGENHARDT L. : Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions : A systematic review and meta-analysis of controlled and observational studies, UNSW, Australia, in press, 2018.
  22. WALKER J.M., HUANG S.M. : Endocannabinoids in pain modulation, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2002, 66, 2-3, 235-242.
  23. WALLACE M.S., MARCOTTE T.D., UMLAUFA. Et al. : Efficacy of inhaled cannabis on painful diabetic neuropathy, Journal of Pain, 2015, 16, 616-627.
  24. WARE M.A., GAMSA A., PERSSON J., FITZCHARLES M.A. : Cannabis for chronic pain : case series and implications for clinicians, Pain Research Management, 2002, 7, 2, 95-99.
  25. WARE M.A., DOYLE C.R., WOODS R., LYNCH M.E., CLARK A.J. : Cannabis use for chronic non-cancer pain : results of a prospective survey, Pain, 2003, 102, 1-2, 211-216.
  26. WARE M.A. et al. : Smoked cannabis for chronic neuropathic pain : a randomized controlled trial, Canadian Medical Association Journal, 2010, 182, 14, 694-701.
  27. WHITING P.F., WOLFF R.F., DESHPANDE S. et al : Cannabinoids for Medical Use. A Systematic Review and Meta-analysis, JAMA, 2015, 313, 24, 2456-2473.
  28. WICKLINE WALLAN S. : Cannabinoid Offers Modest Relief From Pain, Spasticity, 2015,

https://www.medpagetoday.com/PainManagement/PainManagement/52269

  1. WILSEY B., MARCOTTE T., TSODIKOV A. et al. : A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain, Journal of Pain, 2008, 9, 506-521.
  2. WILSEY B., MARCOTTE T., DEUTSCH R. et al. : Low-dose vaporized cannabis significantly improves neuropathic pain, Journal of Pain, 2013, 14, 136-148.
  3. WILSEY B., DEUTSCH R., MARCOTTE T.D. : Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids, Cannabis and Cannabinoid Research, 2016, 1, 1, 139-148.
  4. WOODHAMS S.G., CHAPMAN V., FINN D.P., HOHMAN A.G., NEUGEBAUER V. : The cannabinoid system and pain, Neuropharmacology, 2017, 124, 105-120.
  5. WOODS S. : Evidence for using cannabis and cannabinoids to manage pain, Nursing Times, 2004, 100, 49, 38-40.
  6. WOOLRIDGE et al. : Cannabis use in HIV for pain and other medical symptoms, Journal of Pain Symptom Management, 2005, 29, 358-367.

 

 

 

 

Pièces jointes

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *